Lung Cancer with Pulmonary Embolism:
Evidence-based Progress in Anticoagulation Assessment and Management

Lung cancer is the malignant tumour with the highest incidence and mortality rates globally. Patients with lung cancer face a high risk of developing venous thromboembolism (VTE), particularly pulmonary embolism (PE). This not only prolongs hospital stays and increases inpatient costs but also sever...

Descrición completa

Detalles Bibliográficos

Principais autores:	Yiming MA, Kun LIU, Changling TU, Tongyao XU, Bolin LIU
Formato:	Artigo
Idioma:	Chinês
Publicado:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2025-12-01
Series:	Chinese Journal of Lung Cancer
Assuntos:	lung neoplasms pulmonary embolism anticoagulants risk assessment
Acceso en liña:	http://dx.doi.org/10.3779/j.issn.1009-3419.2025.101.25
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!